Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease CURRENT VASCULAR PHARMACOLOGY Hamburg, N. M., Leeper, N. J. 2015; 13 (3): 316–23

Abstract

Peripheral artery disease (PAD) produces significant disability attributable to lower extremity ischemia. Limited treatment modalities exist to ameliorate clinical symptoms in patients with PAD. Growing evidence links microRNAs to key processes that govern disease expression in PAD including angiogenesis, endothelial function, inflammation, vascular regeneration, vascular smooth muscle cell function, restenosis, and mitochondrial function. MicroRNAs have been identified in circulation and may serve as novel biomarkers in PAD. This article reviews the potential contribution of microRNA to key pathways of disease development in PAD that may lead to microRNA-based diagnostic and therapeutic approaches.

View details for DOI 10.2174/15701611113119990014

View details for Web of Science ID 000357694900005

View details for PubMedID 23713861

View details for PubMedCentralID PMC4886469